Voyager Therapeutics shares are trading lower. The company reported Q2 financial results and Wedbush lowered its price target on the stock from $8 to $7.
Portfolio Pulse from Benzinga Newsdesk
Voyager Therapeutics shares are trading lower after the company reported Q2 financial results and Wedbush lowered its price target from $8 to $7.
August 07, 2024 | 7:32 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Voyager Therapeutics shares are trading lower following the release of Q2 financial results and a price target reduction by Wedbush from $8 to $7.
The combination of disappointing Q2 financial results and a lowered price target from a reputable analyst firm like Wedbush is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100